The objective of this study was to examine whether or not estradiol (E 2 ) alters sodium intake in hypertensive and normotensive female rats. It was hypothesized that higher doses of E 2 would increase sodium consumption and that this response would be greater in spontaneously hypertensive rats (SHR)s compared to Wistar Kyoto(WKY) rats. The study involved female SHR and WKY (n = 12 per group). All animals were ovariectomized. Six of 12 rats from each strain received three progressively larger doses of beta-estradiol propionate (each dose lasting two weeks) while the other 6 rats from each strain received sham implants. Blood E 2 levels were measured by radioimmunoassay after each 2 week period, allowing a 10-day washout period before the next E 2 dose. Rats had access to 0.0, 0.5, 1.0, and 1.5% NaCl solutions to drink throughout the experiment. There was a significant positive correlation between sodium intake and plasma E 2 (r = 0.8, p < .001). Both strains avoided the 1.5% NaCl and the increased sodium intake was achieved by an increase in consumption of the 0.5% NaCl. SHR females consumed more Na than WKY females which is similar to what has been observed in males of these strains.
Introduction
The free sodium intake (ingestion of sodium by animals in neutral or positive sodium balance) of female mammals of most species is greater than males of the same species 4, 5, 9, 10, 14, 16, 17, 19, 20, 21 . Also we have shown in males that one component driving sodium appetite was the sympathetic nervous system since an alpha adrenergic blocker (phentolamine), a norepinephrine depletor (reserpine) 1 and clonidine which blocks central SNS outflow, all reduced sodium consumption in SHR and WKY 1, 10 . Other mechanisms have been reported showing ACTH and the renin-angiotensin system can increase salt appetite 5, 11, 13 . However, the role of the sex hormones upon sodium appetite has not been evaluated systematically. A few studies 3, 6, 7, 25 have shown elevated sodium appetite in pregnancy and during lactation Therefore, experiments were designed to test the hypothesis that estrogen (E 2 ), increases salt appetite in females and there would be a greater sodium intake in the hypertensive strain due to higher sympathetic activity than in the normotensive strain as reported in males 1, 10 .
4 bottle to the nearest 0.1g and calculating fluid and sodium consumption. Rats were also weighed to the nearest gram at the beginning, middle, and end of the experiment.
All rats studied were ovariectomized. Rats were sedated with 50mg/kg Brevital (Eli Lilly & Co, Indianapolis, Indiana) and their ovaries were then surgically removed. After a recovery period of 2 weeks, E 2 implants were administered subcutaneously at the base of the neck to half of the SHR rats (n = 6) and half of the WKY rats (n = 6). These implants were composed of Silastic tubing (Dow Corning Midland) containing β-estradiol propionate given in three different doses to each rat (6 SHR and 6 WKY). This was accomplished by changing the length of the implant tube. The first implant was 4mm in length, the second was 7.5mm in length, and the third was 15mm in length. The ends were then sealed with Silastic medical-grade silicone adhesive (Type A, Dow Corning). Before surgical implantation, the implants were immersed overnight in 5% bovine serum albumin and soaked in 70% ethanol one hour before surgery.
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Each implant remained in the rat for a period of two weeks; however, there was a ten-day washout period before a new implant was placed into the rat. This allowed estrogen levels to fall back to normal levels. The other 6 SHR and 6 WKY rats were given sham implants to provide control for the experiment. The sham implants remained in these rats for the duration of the experiment. Two weeks after each implantation, just before the E 2 implant was to be removed, all rats (including sham rats) were again sedated (50mg/kg Brevital) and a retro-orbital blood sample was taken to determine serum estrogen levels. Plasma E 2 levels were measured by radioimmunoassay (ICN Pharmaceuticals, Costa Mesa, CA). The estrogen kit measured total estrogens with the following percentage cross reactivity: 17 β-estradiol = 100, estriol = 9, 17 α-estradiol = 7, the remainder of the steroids was < 0.01. The percent coefficient of variation for the range we measured was 5.5 for intra-assay and 10.9 for inter-assay variation. The E 2 plasma levels produced by the varying length of implants were several fold higher than normal E 2 levels in our rats which range from 25-50 pg/ml over a 4 day cycle. Two-way and three-way ANOVAs were performed using: strain, E 2 dose, and NaCl concentration preference with follow up posthoc analysis if the F-test was significant. Linear regression was performed on E 2 dose and Na consumption. Significance was assumed if p<0.05.
Results
Estrogen levels for rats given sham implants were not measurable. Plasma E 2 levels were significantly higher for the 7.5mm implant compared to the 4mm implant in both strains (for SHR, p< 0.05, for WKY, p< 0.001, Fig. 1 ). Plasma E 2 levels did not change significantly in either strain between the 15mm implant as compared to the 7.5 mm implant.
The SHR rats' sodium consumption decreased (50%) with the 4mm implant compared to it's sham control. The 7.5mm implant produced a 190% increase (P< 0.05), in sodium consumption compared to it's sham control. The 15mm implant produced a 218% increase (P< 0.05), in sodium consumption compared to it's sham control (Fig. 2) . The WKY rats showed a similar trend with the 4mm implant decreasing sodium consumption by 62% compared to the respective sham control. The 7.5mm implant and 15mm implant increased sodium consumption 79%(P<.01) and 67%(P<.05) respectively compared to the respective sham control (Fig. 2) .
A significant strain effect was also noted. When given the 4mm E 2 implant, SHR rats consumed 28% more NaCl than WKY rats (P< 0.05). When given the 7.5mm E 2 implant, SHR rats consumed 11% more NaCl than WKY rats (nonsignificant). When given the 15mm E 2 implant, SHR rats consumed 39% more NaCl than WKY rats (P< 0.05)
There was a strong implant type -Na preference effect (F = 19.8, P< 0.0001). The rats given the 7.5mm and 15mm E 2 implants had a significant preference for the 0.5% solution compared to the 0.0% solution. (P< 0.001 for both). The SHR 7.5mm E 2 group drank significantly more 0.5% NaCl than did the 4mm E 2 group ( Fig. 3) . WKY animals showed a similar implant typeNa preference effect with most groups preferring the 0.5% NaCl solution (F = 13.9, P< 0.0001, Fig. 4 ). Table 1 shows that there was a significant strain, E 2 implant, and bottle concentration effect (P< 0.001 for all). Also there were significant interactions due to SHR animals consuming more sodium than WKY animals by drinking more of the 0.5% NaCl solution and at higher E 2 levels even higher volumes of the 0.5% NaCl were consumed.
There was a significant positive correlation between plasma E 2 levels and daily sodium intake (r = 0.800, F = 23.149, P< 0.001, Fig. 5 ). Since rats were housed two per cage, the total plasma E 2 level per cage was compared with the total sodium consumed per cage and averaged.
Discussion
Female mammals of most species consume more sodium than do males of that same species 2, 4, 9, 14, 16, 17 . However, other studies have shown that E 2 inhibits sodium appetite in the rat 27, 31 . The difference in these studies was either the test period was short from 8 hours -2 days, which does not allow enough time for hormones to have their full affect, or the animals were sodium deprived which could have a significant impact on the sodium intake 31 .
In the present study, the increased sodium intake associated with higher plasma E 2 levels was mostly due to an increase in consumption of 0.5% NaCl rather than an increase in consumption of a higher concentration of NaCl. This was most likely the result of the higher salt concentration being taste aversive. Our results support those of Fregly and Newsome 15 who showed in female Sprague Dawley and Long-Evans Hooded rats that oral contraceptives increased salt appetite within 1 week of drug administration in a dose response relationship. The results of this experiment confirm our findings and extend to show that the adrenal gland may play a role in salt appetite because oral contraceptives in adrenalectomized rats failed to have an affect. Also our data is supported by that of Chow et al. who showed that female rats drank more 3% NaCl than males both in need-free and need-induced states 2 . They did not manipulate E 2 levels but they did castrate males at a young age and as adults they consumed NaCl like females.
Also females given testosterone consumed less need-free NaCl which suggests that testosterone inhibits Na intake.
It does not appear that E 2 works through the renin-angiotensin-aldosterone system 8, 12 , since estrogen has been shown to actually lower levels of renin. Indeed, Schunkert et al.
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showed that women replacing E 2 during menopause presented with significantly lower renin levels than those not using such therapy.
Another mechanism for enhanced salt appetite in males is enhanced activation of the sympathetic nervous system (SNS). 1 The concept of SNS involvement is that in the SHR model of hypertension we have shown increased intestinal sodium loss compared to normotensive WKY animals and as a compensation to sodium loss the SNS may be activated to help reabsorb sodium from the intestinal tract 30 . However, elevated SNS in our SHR females being responsible for sodium appetite does not seem to be completely responsible. For example, Li and Duckles have shown that sensitivity to adrenergic nerve stimulation in rat tail arteries was lower in females as compared to males. 22 In addition we have evidence that the SNS is not primarily involved in salt appetite in females. For example, clonidine decreased sodium intake in male SHR and WKY, but not in female WKY and only partially decreased it in SHR females 10 .
The increased sodium appetite in females may be an adaptation for possible pregnancy and the conservation of sodium and other electrolytes 15 . Pregnancy implies a challenge to sodium homeostasis, leading to a natural episode of increased sodium need and intake 14,23,24,26, . There are many hormonal and physiological changes that occur in pregnancy many which can influence sodium homeostasis 18, 24 . For instance, sodium is crucial for the developing fetus and for milk production 3 . Increases in blood volume and tissue fluid required during pregnancy can be achieved through an increase in maternal water and sodium intake 21 .
Experiments using E 2 and progesterone show that hormonal changes alone are adequate to produce an increase in salt appetite. For instance, Covelli et al. 3 injected wild rabbits with E 2 and progesterone for 14 days which increased sodium intake over two-fold and remained elevated for 3-5 days after injections ceased. This effect using E 2 and progesterone was 50% greater than that observed with the same dose of E 2 alone. It was also found that the increased salt appetite effect using 25 µg E 2 /day was maximal; a tenfold increase in E 2 did not result in further enhancement.
With regard to E 2 plasma levels in our study, they were high compared to control females, however the sodium intake compared to the same strain control females from another study in our lab shows that sodium intake in WKY control females was 107 mg NaCl/100g/24hr and in control SHR females was 133 mg NaCl/100g/24hr 10 . In the present study the E 2 increased sodium intake in WKY females to 175mg NaCl/100g/24hr and SHR females to 200 mg NaCl/100g/24hr with the highest E 2 dose. therefore, even with high E 2 levels the percentage increase in sodium intake was comparable to that of other studies 2,3,15 .
In conclusion, increased levels of plasma E 2 caused significantly higher intake of 0.5% NaCl in drinking water and therefore, higher total sodium intake in WKY and SHR females. However, there was not an increase in preference for a higher NaCl concentration. Our data support the concept that in SHR females, as in SHR males, there is an increase sodium appetite compared to both genders of WKY. This finding may have important implications for women during pregnancy when E 2 levels are elevated and those on E 2 replacement therapy since increased sodium intake could adversely affect blood pressure and total blood volume putting an extra load on the heart. Figure 4 . Sodium preference of WKY based on NaCl solution intake by each implant group (n=6/group, means, ± SE). Two-way ANOVA test (E 2 dose -F = 31.95, p<.001, solution preference -F = 34.2, p<.001, E 2 dose x preference -F = 13.9, p<.001, * P= < .05 for 15mm E 2 vs. 7.5 mm E 2 for same Na concentration, **= P <.01 for 15mm E 2 vs. 7.5mm E 2 and 7.5mm E 2 vs. 4mm E 2 compared for the same Na concentration). 
